Treatment efficacy of BCAA on cognitive function and driving skill in patients with MHE

Korea University Ansan Hospital0 个研究点目标入组 80 人开始时间: 待定最近更新: 2019年3月25日

试验速览

暂无简介。

•.1) Persons 20 years of age or older and 65 years of age or younger
•2) cirrhosis
•: Liver cirrhosis has been diagnosed by liver biopsy or one of the following 5 cases; (1) Image examination: The liver cirrhosis, including the nodular liver surface, morphologic changes in the liver (nodularity of the liver surface, atrophy of the right and left lobes, enlargement of the left and right lobes, enlargement of the portal vein, (2) upper gastrointestinal endoscopy (presence or absence of varices), (3) peripheral blood red blood cell count test (platelet reduction (=100,000 / mm3) Albumin reduction (=3.5 g / dL)), (5) prothrombin time extension (INR =1.3)
•3) Those who have written consent before the commencement of research and are able to comply with the requirements of the research.

•,One or more of the following exclusion criteria:
•1) A person who has been treated or is taking medication due to a neurological or psychiatric disorder that may affect the study as determined by the tester.
•2) Those who are being treated for uncontrolled liver cancer and other malignancies
•3) Those with viable hepatocellular carcinoma
•4) Any infected or gastrointestinal bleeding within 6 weeks.
•5) Those who had a history of mild hepatic encephalopathy within 3 months
•6) Those with a history of BCAA, rifaximin, lactulose prescription within the last month.
•7) Continued uncontrolled drinking patients
•8) A person who is deemed impossible to study due to audiovisual disorder

发起方